Toxicity and efficacy probability intervals design for phase I dose-finding in oncology trials

被引：1
|
作者：
Li, Daniel H.
Whitmore, Jim
Ji, Yuan
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-423
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
423
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Probability intervals of toxicity and efficacy design for dose-finding clinical trials in oncology
    Lin, Xiaolei
    Ji, Yuan
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2021, 30 (03) : 843 - 856
  • [2] Dose-finding in phase I clinical trials based on toxicity probability intervals
    Ji, Yuan
    Li, Yisheng
    Bekele, B. Nebiyou
    [J]. CLINICAL TRIALS, 2007, 4 (03) : 235 - 244
  • [3] Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials
    Li, Daniel H.
    Whitmore, James B.
    Guo, Wentian
    Ji, Yuan
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (01) : 13 - 20
  • [4] Checkerboard: a Bayesian efficacy and toxicity interval design for phase I/II dose-finding trials
    Yin, Jun
    Yuan, Ying
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2020, 30 (06) : 1006 - 1025
  • [5] Bayesian hybrid dose-finding design in phase I oncology clinical trials
    Yuan, Ying
    Yin, Guosheng
    [J]. STATISTICS IN MEDICINE, 2011, 30 (17) : 2098 - 2108
  • [6] Dose-finding with two agents in phase I oncology trials
    Thall, PF
    Millikan, RE
    Mueller, P
    Lee, SJ
    [J]. BIOMETRICS, 2003, 59 (03) : 487 - 496
  • [7] An integrated dose-finding tool for phase I trials in oncology
    Yang, Shengjie
    Wang, Sue-Jane
    Ji, Yuan
    [J]. CONTEMPORARY CLINICAL TRIALS, 2015, 45 : 426 - 434
  • [8] uTPI: A utility-based toxicity probability interval design for phase I/II dose-finding trials
    Shi, Haolun
    Cao, Jiguo
    Yuan, Ying
    Lin, Ruitao
    [J]. STATISTICS IN MEDICINE, 2021, 40 (11) : 2626 - 2649
  • [9] Target toxicity design for phase I dose-finding
    Guo, Wenchuan
    Zhong, Bob
    [J]. STATISTICAL THEORY AND RELATED FIELDS, 2021, 5 (02) : 149 - 161
  • [10] Bayesian optimization design for dose-finding based on toxicity and efficacy outcomes in phase I/II clinical trials
    Takahashi, Ami
    Suzuki, Taiji
    [J]. PHARMACEUTICAL STATISTICS, 2021, 20 (03) : 422 - 439
12345